A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects with Mild to Moderate Alzheimer's Disease
Clinical Trial Grant
Administered By
Neurology, Behavioral Neurology
Awarded By
Athira Pharma, Inc.
Start Date
April 12, 2021
End Date
December 31, 2024
Administered By
Neurology, Behavioral Neurology
Awarded By
Athira Pharma, Inc.
Start Date
April 12, 2021
End Date
December 31, 2024